Nantahala Capital Management, LLC Alector, Inc. Transaction History

Nantahala Capital Management, LLC

  • $1.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$8.19 - $13.2 $54,561 - $87,938
-6,662 Reduced 7.23%
85,514 $809,000
Q2 2022

Aug 15, 2022
SELL
$7.65 - $14.24 $19,912 - $37,066
-2,603 Reduced 2.75%
92,176 $937,000
Q1 2022

May 13, 2022
BUY
$13.02 - $20.78 $1.23 Million - $1.97 Million
94,779 New
94,779 $1.35 Million

Others Institutions Holding ALEC

# of Institutions
165
Shares Held
58.1M
Call Options Held
57K
Put Options Held
14.9K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $386M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email